<- Go Home

ANI Pharmaceuticals, Inc.

ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic pharmaceutical products in the United States and internationally. The company provides injectables, softgel capsules, and Cortrophin gel, as well as ILUVIEN and YUTIQ products. It also manufactures oral solid dose products, semi-solids, liquids, topicals, controlled substances, and potent products. The company serves its products to national wholesalers, specialty pharmacies, retail pharmacy chains, distributors, mail order houses, group purchasing organizations, and hospitals and healthcare providers. ANI Pharmaceuticals, Inc. was incorporated in 2001 and is headquartered in Baudette, Minnesota.

Market Cap

$1.7B

Volume

416.7K

Cash and Equivalents

$311.2M

EBITDA

$197.4M

Tax Rate Collected

N/A

Tax Rate Ratio

N/A

Gross Profit

$561.9M

Profit Margin

60.83%

52 Week High

$99.50

52 Week Low

$56.71

Dividend

N/A

Price / Book Value

3.07

Price / Earnings

20.72

Price / Tangible Book Value

52.87

Enterprise Value

$2.0B

Enterprise Value / EBITDA

10.04

Operating Income

$107.9M

Return on Equity

18.32%

Return on Assets

4.97

Cash and Short Term Investments

$326.1M

Debt

$630.2M

Equity

$562.3M

Revenue

$923.7M

Unlevered FCF

$160.0M

Sector

Pharmaceuticals

Category

N/A

Company Stock Pitches